Giken Holdings, First Half Ordinary Profit Increases by 51%, Jul-Sep Ordinary Profit Increases by 2.1 times
1443 Giken Holdings Co.,Ltd. 【J-GAAP】
Earnings ReportGiken Holdings Co.,Ltd. <1443> [TSE Std] announced its financial results after the market closed on November 14th (15:35). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) expanded 480 million yen, an increase 50.9% compared to the same period last year. Progress toward the full-year plan of 750 million yen was 64.0%, also surpassing the five-year average of 44.8%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to drop 40.3% from the same period last year to 270 million yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit surged 2.1 times that of the same period last year, reaching 201 million yen. The operating profit margin drastically improved from 9.8% in the same period last year to 17.6%.
Kabutan News
Actual Performance and Financial Trends
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Progress Rate vs. First Half |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
2,635M | 208M | 314M | 188M | 11.6 | 49.1 | Nov 14, 2023 | J-GAAP |
|
|
2,265M | 226M | 318M | 223M | 13.8 | 41.3 | Nov 14, 2024 | J-GAAP |
|
|
2,186M | 362M | 480M | 333M | 20.5 | 64.0 | Nov 14, 2025 | J-GAAP |
| YoY | -3.5% | +60.2% | +50.9% | +49.3% | +48.8% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | － | 0 | May 20, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 2,186M | 362M | 480M | 333M | 20.5 | 0 | Nov 14, 2025 | J-GAAP |
| Revision Rate | － | － | － | － | － |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
2,641M | 397M | 452M | 268M | 16.5 | 1.10 | May 20, 2025 | J-GAAP |
|
Guidance
Oct - Mar, 2025
|
2,714M | 238M | 270M | 147M | 9.1 | 1.10 | Nov 14, 2025 | J-GAAP |
| YoY | +2.8% | -40.1% | -40.3% | -45.1% | -45.2% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
5,169M | 529M | 640M | 444M | 27.4 | 1 | May 20, 2024 | J-GAAP |
|
|
4,906M | 623M | 770M | 491M | 30.3 | 1.10 | May 20, 2025 | J-GAAP |
|
Guidance
Mar, 2026
|
4,900M | 600M | 750M | 480M | 29.6 | 1.10 | May 20, 2025 | J-GAAP |
| YoY | -0.1% | -3.7% | -2.6% | -2.2% | -2.4% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
1,178M | 116M | 97M | 62M | 3.8 | 9.8 | Nov 14, 2024 | J-GAAP |
|
|
1,305M | 224M | 290M | 191M | 11.8 | 17.2 | Feb 14, 2025 | J-GAAP |
|
|
1,336M | 173M | 162M | 77M | 4.8 | 12.9 | May 20, 2025 | J-GAAP |
|
|
1,018M | 156M | 279M | 209M | 12.9 | 15.3 | Aug 14, 2025 | J-GAAP |
|
|
1,168M | 206M | 201M | 124M | 7.6 | 17.6 | Nov 14, 2025 | J-GAAP |
| YoY | -0.8% | +77.6% | +107.2% | +100.0% | +99.5% |
Related Articles
-
LUCKLAND, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 2.2 times, Exceeded Record Profit Forecast, The Undecided Dividend Set at 20 Yen, Resuming Dividends for the First Time in Three Terms
Fri Nov 14, 2025 3:35 pm JST Earnings -
AIMECHATEC, Jul-Sep (1Q) Ordinary Profit Turns to Profit
Fri Nov 14, 2025 3:35 pm JST Earnings -
Delta-Fly Pharma, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
Fri Nov 14, 2025 3:35 pm JST Earnings -
Future Innovation Group, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 87%, Jul-Sep Ordinary Profit Increases by 5.8 times
Fri Nov 14, 2025 3:35 pm JST Earnings -
KLASS, 48% Increase in Ordinary Profit for The Current Fiscal Year
Fri Nov 14, 2025 3:35 pm JST Earnings -
BrightPath Biotherapeutics, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
Fri Nov 14, 2025 3:32 pm JST Earnings -
VELTRA, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 77%
Fri Nov 14, 2025 3:31 pm JST Earnings -
LIFE CREATE, First Half Ordinary Profit Turns to Loss
Fri Nov 14, 2025 3:31 pm JST Earnings -
CRESTEC, Jul-Sep (1Q) Ordinary Profit Increases by 2.5 times
Fri Nov 14, 2025 3:31 pm JST Earnings -
eWeLL, Jul-Sep (3Q) Ordinary Profit Increases by 39%, Current Fiscal Year Dividend Revised Upward by 1 Yen
Fri Nov 14, 2025 3:31 pm JST Earnings